[an error occurred while processing this directive]
BBC News
watch One-Minute World News
Last Updated: Friday, 23 December 2005, 10:13 GMT
AstraZeneca buys UK cancer firm
Worker in AstraZeneca laboratory
AstraZeneca sees Kudos as central to its cancer work
Anglo-Swedish drugs giant AstraZeneca has agreed to buy privately owned UK biotech firm Kudos Pharmaceuticals in an all-cash 121m deal.

Founded by Cambridge University professor Stephen Jackson, Kudos is a cancer research specialist with 75 staff at two sites in the UK.

It uses DNA science to enhance chemotherapy and radiotherapy drugs.

AstraZeneca said it wanted Kudos to become the hub of its research into treating cancer using DNA.

Kudos currently has one compound in clinical development which could help fight breast and ovarian cancer, in addition to several other pre-clinical compounds and other programmes.

AstraZeneca is Europe's third-largest drugs company.


SEE ALSO:
Giant deal for small drugs firm
08 Dec 05 |  Business
New drugs fuelling AstraZeneca
22 Jul 04 |  Business
US runs low on snakebite antidote
15 Jun 02 |  Americas


RELATED INTERNET LINKS:
The BBC is not responsible for the content of external internet sites


PRODUCTS AND SERVICES

Americas Africa Europe Middle East South Asia Asia Pacific